About: Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2006 (uk) article scientifique (publié 2006) (fr) im Jahr 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2006 (ast) artikull shkencor i botuar më 01 janar 2006 (sq) scientific article published on 01 January 2006 (en)
publication date	wds:Q79750655-68BA58EF-8D91-42E3-86D0-307D2FB9DF7F
publication date	2006-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q79750655-03028BCD-0FDC-45D6-8A1A-4E0DF66CD80F wds:Q79750655-0D4E7EFC-3B2B-441A-9BB5-2C77E4FCCD69 wds:Q79750655-20BEAFB7-A745-4498-BA82-E080B785C357 wds:Q79750655-565AA196-D48C-454D-8949-0E3CB7EA669B wds:Q79750655-57FCE41D-A0A8-48ED-9498-AD5A49987E23 wds:Q79750655-6A88E038-E9AF-4CCC-BB8C-EAF034BC53C1 wds:Q79750655-6FB1B6C6-40BC-4F4F-98AF-DB4BB4D5A0EB wds:Q79750655-818B9904-4595-45C8-A81C-FD8C4B7E01B8 wds:Q79750655-9071496F-B4AE-48D8-AAC2-F844425E3891 wds:Q79750655-9F02448A-62ED-4C29-A13E-16A33DFAC994 wds:Q79750655-A4A6657C-5317-4F0E-8F02-0E8070075855 wds:Q79750655-A56822E8-568A-429C-AFC4-C834708934C0 wds:Q79750655-B06B4214-EF08-4483-BBDD-CDE60C594942 wds:Q79750655-B84CC8BF-B26F-407B-9B32-5097DF9CDCC7 wds:Q79750655-C525B16D-208D-42A5-8848-4B1B581361B4 wds:Q79750655-CA6527FE-2FE3-440C-BD21-62DAA67D7B89 wds:Q79750655-D874B9CE-4AE5-445B-9DDC-FD2FFE3A0064 wds:Q79750655-D9DAFD44-3A81-4591-B6D1-CF1E1DA7C747 wds:Q79750655-DCE78E38-1BC0-47FB-B10D-F358B45C4524 wds:Q79750655-FAE13979-94EA-4435-9699-8966E9CE84DC
cites work	Cancer statistics, 2005 Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037) Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus Tumor response to induction chemoradiation: influence on survival after esophagectomy☆ Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study.
author name string	wds:Q79750655-114FACC3-7DC9-4F67-9DF4-52A3636BD35A wds:Q79750655-118F556A-583D-4D92-A8BB-9CAB7FAAA0E3 wds:Q79750655-1295FE4C-E9E5-4B52-8447-35D0E8C678C3 wds:Q79750655-26044B84-48FD-4792-8423-73099537685B wds:Q79750655-6191D169-E35B-4648-9213-CBAFF993551B wds:Q79750655-636B2C6A-275A-4B2C-B270-1AEEA5AA2C55 wds:Q79750655-8DF7BCE3-55D5-41AE-AE64-640A6658DC31 wds:Q79750655-CDC0713D-6663-4453-8EA1-E85B4FB7B377 wds:Q79750655-DD7EA3A9-2E19-41DC-ACE8-8918E632C326
author name string	James Lovato Edward A Levine A William Blackstock Girish Mishra Kim Geisinger Mabea Aklilu Michael R Farmer Susan A Melin Timothy Oaks
rdfs:label	Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (en) Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (nl) Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (sq)
skos:prefLabel	Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (en) Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (nl) Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (sq)
name	Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (en) Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (nl) Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (sq)
title	wds:Q79750655-74E43AC3-4E93-4C9D-93DF-3A7851C6084C
title	Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer (en)
page(s)	wds:Q79750655-B6259BF5-A959-4B4F-8F0B-5E37F0E546F2
page(s)	7-14
instance of	wds:Q79750655-F47DB552-2A86-4372-8D86-2E6FFEDC1F9E
instance of	scholarly article
main subject	wds:Q79750655-BF900C5E-EA2D-4851-8AFB-2F305F7C0156
main subject	esophageal cancer
PubMed ID	wds:Q79750655-5A316F1A-656C-40E9-A44E-44DE5402D38E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17290076
PubMed ID	17290076
published in	wds:Q79750655-D6EADCCB-B77D-4C4B-8B60-8E9F03F60FAA
published in	International Journal of Gastrointestinal Cancer
issue	wds:Q79750655-F7205F3D-002E-4094-AED4-62718F828C72
volume	wds:Q79750655-D86C3ADB-A6CA-43F6-B3BF-44E4FB1374C7
issue	1
volume	37
DOI	wds:Q79750655-192A94DC-D7D8-4B08-8792-8A923A4354C6
DOI	http://dx.doi.org/10.1385/IJGC:37:1:7
DOI	10.1385/IJGC:37:1:7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79750655
is cites work of	Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software